Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2026-04-07 @ 3:57 PM
Study NCT ID:
NCT05329051
Status:
UNKNOWN
Last Update Posted:
2022-04-14
First Post:
2022-04-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 Years
Sponsor:
Sinocelltech Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SCTV01E-01-mRNA-BRA-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None